Your email has been successfully added to our mailing list.

×
-0.0256410256410257 -0.0256410256410257 -0.0256410256410257 -0.0256410256410257 -0.0256410256410257 0 -0.0128205128205128 -0.0128205128205128
Stock impact report

DEVELOPMENT UPDATE FOR ARTIVEDA™/ARTISHIELD™ AGAINST COVID-19

MATEON THERAPEUTICS (MATN) 
Last mateon therapeutics earnings: 11/19 05:25 pm Check Earnings Report
US:NASDAQ Investor Relations: investor.mateon.com
Company Research Source: GlobeNewswire
--75% IMPROVEMENT BY DAY 2 ON ARTIVEDA™ COVID-19 AGOURA HILLS, California, Nov. 30, 2020 (GLOBE NEWSWIRE) -- Mateon Therapeutics, Inc. (OTCQB: MATN) (“Mateon”), a leading developer of TGF-ß therapeutics for oncology and COVID-19, provided development update for ARTIVedaTM/ArtiShieldTM against COVID-19. ARTIVedaTM is Mateon’s lead Ayurvedic drug against COVID-19 in India and ArtiShieldTM is for Rest-of-World. The India arm of ARTI-19 global study is on track to complete enrollment of the first 120 cohort by Dec 15, 2020, of which 78 patients have already been randomized.Interim analysis of the first 32 pts (8 WHO scale 2 and 24 WHO scale 4 on randomization) was performed.Statistical significant Time dependent improvement in WHO scale following treatment with ARTIVedaTM+SOC v Show less Read more
Impact Snapshot
Event Time:
MATN
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison Updated
Event Day
Stock performance from the time of news release until the following 4pm ET market close
Last price at news event
Since Event
Multi-day stock performance from the time of the news release
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
LAST
PRICE AT
NEWS EVENT
SINCE EVENT
Multi-day stock performance from the time of the news release
Last Price
VWAP
High:
Max Up
High:
Low:
Max Down
Low:
%
Post news range
%
Price change

Price Change Percentage


S&P 500
(SPX)

%

Volume ratio
%

Volume
Ticks

Avg transaction size

Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Opt-in for MATN alerts
Opt-in for
MATN alerts

from News Quantified
Opt-in for
MATN alerts

from News Quantified